Bioactive polysaccharides and their potential health benefits in reducing the risks of metabolic syndrome: A review
Open Access
- 26 July 2025
- journal article
- review article
- Published by Wiley in Food Biomacromolecules
Abstract
Metabolic syndrome (MetS) is a complex noncommunicable condition characterized by central obesity, insulin resistance, hyperlipidemia, hypertension, and hyperglycemia. Epidemiological evidence shows that MetS affects a third of the global population; however, due to its complex pathogenesis and limited drug therapy options, the increasing prevalence is a global public health concern. Consequently, there is increasing interest in natural, novel, safe, and effective supplementary therapies to the existing drug and surgical interventions for treating metabolic diseases. Bioactive polysaccharides characterized by low toxicity, high ubiquity, and physiological properties have attracted much attention in the regulation of MetS. Recently, bioactive polysaccharides have been shown to maintain glucose homeostasis, reduce insulin resistance, and prevent diabetes and obesity complications; however, the mechanisms responsible for specific effects related to the prevention and management of MetS is still unclear. This review discusses the effects and underlying mechanisms of bioactive polysaccharides in preventing and managing metabolic diseases by improving glycolipid metabolism, alleviating systemic inflammation, and modulating gut microbiota. Furthermore, the contribution of the structure‐activity relationship is advanced where possible. The findings on the biomechanisms provide mechanistic insight into the safe and dependable application of bioactive polysaccharides in reducing MetS‐associated risks.Keywords
This publication has 206 references indexed in Scilit:
- The interaction of innate immune and adaptive immune systemMedcomm, 2024
- Inulin‐type fructans with different degrees of polymerization improve insulin resistance, metabolic parameters, and hormonal status in overweight and obese women with polycystic ovary syndrome: A randomized double‐blind, placebo‐controlled clinical trialFood Science & Nutrition, 2023
- The Influence of Polysaccharides on Lipid Metabolism: Insights from Gut MicrobiotaMolecular Nutrition & Food Research, 2023
- Signaling pathways in macrophages: molecular mechanisms and therapeutic targetsMedcomm, 2023
- Lipid metabolism in cancer progression and therapeutic strategiesMedcomm, 2020
- Poria cocos polysaccharides reduces high‐fat diet‐induced arteriosclerosis in ApoE−/− mice by inhibiting inflammationPhytotherapy Research, 2020
- Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathwayArchives of Biochemistry and Biophysics, 2019
- An anti-inflammatory effect of red microalga polysaccharides in coronary artery endothelial cellsAtherosclerosis, 2017
- Arabinoxylan activates lipid catabolism and alleviates liver damage in rats induced by high‐fat dietJournal of the Science of Food and Agriculture, 2017
- Activation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase during high fat diet feedingBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013